Fort Worth-based healthcare mergers and acquisitions firm VERTESS has closed on five major healthcare transactions in Q3 2023 with a combined total transaction value of $75 million, the company said.
VERTESS’ Vaughne Glennie
The five transactions were in “various healthcare verticals.”
VERTESS said that the headwinds faced earlier in the year because of global and domestic economic pressures are clearing and signs for a profitable Q4 and 2024 are strong.
“At the end of 2022 and early 2023, we saw a sharp decline in the pace of M&A activity,” Bradley Smith, managing director for one of the sellers, said in a statement. “We continued to push forward and remain patient. We’re pleased for our clients that our perseverance with buyers resulted in several successes.”
VERTESS said the healthcare verticals for the five closed transactions included pediatric-focused home medical equipment and service providers, home healthcare services, custom rehab and durable medical equipment, as well as retail pharmacy.
The firm added that more than half of VERTESS’ managing directors successfully closed deals in Q3.
“We’re encouraged by the uptick in deal activity at the end of 2023,” VERTESS Managing Partner Vaughne Glennie said in a statement. “Although the dry powder remained available for many buyers, there was clearly some risk avoidance starting in mid-2022. As we continue to launch new deals this fall, the heightened response we’ve received from buyers clearly shows a trend toward a very active 2024 in healthcare M&A.”
“Our managing directors are always available to talk to healthcare business owners about their future goals and to be a resource for any exit planning,” Glennie added.
VERTESS is an international healthcare-focused M&A advisory firm with expertise spanning diverse healthcare and human service verticals, ranging from behavioral health and intellectual/developmental disabilities to DME, pharmacies, home care/hospice, urgent care, life sciences, and other specialized services and products.
In 2022, VERTESS added three managing directors to its leadership team, naming Rachel Boynton, Anna Elliott, and Robert Villalobos as new partners in the firm.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The Dallas-based provider of digital care management solutions and services has released Aerial Social Care Coordinator—a cutting-edge solution designed to provide health plans and healthcare providers with immediate insight into individuals' social determinants of health barriers.
-
Bio 9 Ventures, a Plano-based boutique healthcare ecosystem consulting firm, has merged its international healthcare IT division with three companies to form a new business called Kanectify. The new entity will add end-to-end integrated benefits to platform engineering, AI healthcare, and a portfolio of digital health R&D solutions.
-
Yuvo Health, a New York-based technology-enabled administrative and managed-care solution provider for community health centers, announced Coppell executive Selase Dow as its new chief operating officer. Dow, who will remain based in the Dallas-Fort Worth city, brings more than two decades of managed care experience to the New York startup. Dow has worked closely with large physician organizations in North Texas to implement financial and care models and has a deep background in operations, ACO management, contracting, and more. Yuvo Health is a New York-based startup founded in 2021 by a BIPOC founding team. The company aims to provide administrative…
-
Tenet Healthcare Corp. of Dallas announced that former U.S. Sen. Roy Blunt has been appointed to the Tenet board of directors. Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. The company said that his appointment expands the board to 12 directors, 11 of whom are independent members. “We are pleased to welcome Senator Roy Blunt as a new board member,” Tenet CEO Saum Sutaria, M.D., said in a statement. “With more than 25 years of legislative experience, Roy’s expertise in public policy and addressing cross-cutting issues will…
-
The investment from Cobalt Ventures follows MedArrive's $25 million series A round in November 2021 and brings its total funding to $40.5 million to date. "Everyone in America has a right to inclusive, high-quality care, yet too many are left out and have no one on their side who can connect them to the system," MedArrive Co-Founder and CEO Dan Trigub said. "That's what the MedArrive platform and our field providers offer."
